Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 271 AL 285

A Multiform Heterogeneity Framework for Alzheimer's Disease Based on Multimodal Neuroimaging

Zhao K, Chen P, Wang D, Zhou R, Ma G, Liu Y.

Biol Psychiatry. 2025 Jun 1;97(11):1022-1033. doi: 10.1016/j.biopsych.2024.12.009. Epub 2024 Dec 24.

Deoxyvasicinone hybrids in the management of Alzheimer's disease: Recent advances on manmade derivatives, pharmacological activities, and structure-activity relationship

Gaur A, Singh YP, Sharma R, Bainsal N.

Arch Pharm (Weinheim). 2025 Jan;358(1):e2400742. doi: 10.1002/ardp.202400742.

Harnessing the potential of long non-coding RNAs in the pathophysiology of Alzheimer's disease

Kaur R, Pandey S, Gupta S, Singh J.

Exp Neurol. 2025 Mar;385:115134. doi: 10.1016/j.expneurol.2024.115134. Epub 2024 Dec 29.

The Role of Oligodendrocyte Lineage Cells in the Pathogenesis of Alzheimer's Disease

Liu X, Lv Z, Huang Q, Lei Y, Liu H, Xu P.

Neurochem Res. 2025 Jan 3;50(1):72. doi: 10.1007/s11064-024-04325-3.

Inducers and modulators of protein aggregation in Alzheimer's disease - Critical tools for understanding the foundations of aggregate structures

Sun KT, Mok SA.

Neurotherapeutics. 2025 Apr;22(3):e00512. doi: 10.1016/j.neurot.2024.e00512. Epub 2025 Jan 3.

Alterations in the inflammatory homeostasis of aging-related cardiac dysfunction and Alzheimer's diseases

Huang S, Nunez J, Toresco DL, Wen C, Slotabec L, Wang H, Zhang H, Rouhi N, Adenawoola MI, Li J.

FASEB J. 2025 Jan 15;39(1):e70303. doi: 10.1096/fj.202402725RR.

Calcium signaling hypothesis: A non-negligible pathogenesis in Alzheimer's disease

Wang M, Zhang H, Liang J, Huang J, Wu T, Chen N.

J Adv Res. 2025 Nov;77:513-534. doi: 10.1016/j.jare.2025.01.007. Epub 2025 Jan 8.

Prospective Utilization of Nanocarriers Loaded with Drug Combination for Treating Alzheimer's Disease

Khan SA, Qamar Z, Rohilla A, Singh PP, Parvez S, Baboota S, Ali J.

Curr Pharm Des. 2025;31(18):1444-1460. doi: 10.2174/0113816128348877241202053633.

Design, current states, and challenges of nanomaterials in anti-neuroinflammation: A perspective on Alzheimer's disease

Hong X, Chen T, Liu Y, Li J, Huang D, Ye K, Liao W, Wang Y, Liu M, Luan P.

Ageing Res Rev. 2025 Mar;105:102669. doi: 10.1016/j.arr.2025.102669. Epub 2025 Jan 27.

Sleep-wake modulation and pathogenesis of Alzheimer disease: Suggestions for postponement and treatment

Liu YJ, Swaab DF, Zhou JN.

Handb Clin Neurol. 2025;206:211-229. doi: 10.1016/B978-0-323-90918-1.00001-0.

Mitochondrial dysfunction in Alzheimer's disease: a key frontier for future targeted therapies

Wang S, Liao Z, Zhang Q, Han X, Liu C, Wang J.

Front Immunol. 2025 Jan 14;15:1484373. doi: 10.3389/fimmu.2024.1484373. eCollection 2024.

Uncovering the intricacies of IGF-1 in Alzheimer's disease: new insights from regulation to therapeutic targeting

Kaur N, Aran KR.

Inflammopharmacology. 2025 Mar;33(3):1311-1330. doi: 10.1007/s10787-025-01641-0. Epub 2025 Jan 30.

Melatonin Overexpression in the Management of Alzheimer's Disease: Therapeutic Exploration

Gupta B, Malviya R, Sundram S, Sridhar SB, Singh DP.

Curr Top Med Chem. 2025;25(15):1783-1794. doi: 10.2174/0115680266327614241121050448.

Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research

Smith EE, Phillips NA, Feldman HH, Borrie M, Ganesh A, Henri-Bhargava A, Desmarais P, Frank A, Badhwar A, Barlow L, Bartha R, Best S, Bethell J, Bhangu J, Black SE, Bocti C, Bronskill SE, Burhan AM, Calon F, Camicioli R, Campbell B, Collins DL, Dadar M, DeMarco ML, Ducharme S, Duchesne S, Einstein G, Fisk JD, Gawryluk JR, Grossman L, Ismail Z, Itzhak I, Joshi M, Harrison A, Kröger E, Kumar S, Laforce R, Lanctot KL, Lau M, Lee L, Masellis M, Massoud F, Mitchell SB, Montero-Odasso M, Myers Barnett K, Nygaard HB, Pasternak SH, Peters J, Rajah MN, Robillard JM, Rockwood K, Rosa-Neto P, Seitz DP, Soucy JP, Trenaman SC, Wellington CL, Zadem A, Chertkow H; Canadian Consortium on Neurodegeneration in Aging Investigators.

J Prev Alzheimers Dis. 2025 Mar;12(3):100068. doi: 10.1016/j.tjpad.2025.100068. Epub 2025 Jan 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias